BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Prognosis
29 results:

  • 1. The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms.
    d'Izarny-Gargas T; Isnard P; Boudhabhay I; Buob D; Moktefi A; Linster C; Hummel A; Esteve E; Audard V; Lazareth H; Maroun N; Hertig A; Gosset C; Jouzel C; Permal S; Domenger C; Kosmider O; Rabant M; Karras A; Duong Van Huyen JP
    Kidney Int; 2023 Dec; 104(6):1206-1218. PubMed ID: 37769965
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Enhancing information on stage at diagnosis for childhood cancer in Africa.
    Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
    Gama A; Xu H; Yang XJ; Choy B
    Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
    [No Abstract]    [Full Text] [Related]  

  • 4. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
    Shen Q; Liu YX; He Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A rare case of Klippel-Trenaunay syndrome presenting with chronic myeloid leukemia.
    Coşkun Ç; Aksu T; Gümrük F; Ünal Ş
    Turk J Pediatr; 2023; 65(1):124-128. PubMed ID: 36866992
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
    Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
    Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approach.
    Laukhtina E; Schuettfort VM; D'Andrea D; Pradere B; Quhal F; Mori K; Sari Motlagh R; Mostafaei H; Katayama S; Grossmann NC; Rajwa P; Karakiewicz PI; Schmidinger M; Fajkovic H; Enikeev D; Shariat SF
    World J Urol; 2022 Mar; 40(3):747-754. PubMed ID: 34671856
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nuclear overexpression levels of MAGE-A3 predict poor prognosis in patients with prostate cancer.
    Khalvandi A; Abolhasani M; Madjd Z; Shekarabi M; Kourosh-Arami M; Mohsenzadegan M
    APMIS; 2021 Jun; 129(6):291-303. PubMed ID: 33743542
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sarcomatoid renal cell carcinoma: biology, natural history and management.
    Blum KA; Gupta S; Tickoo SK; Chan TA; Russo P; Motzer RJ; Karam JA; Hakimi AA
    Nat Rev Urol; 2020 Dec; 17(12):659-678. PubMed ID: 33051619
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
    Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
    BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Retrospective Analysis of Mortality Cases in Advanced and Metastatic Solid tumors With Concurrent Prerenal Azotemia.
    Liao TY; Liaw CC
    In Vivo; 2020; 34(3):1515-1519. PubMed ID: 32354956
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.
    Kodama H; Koie T; Oikawa M; Narita T; Tanaka T; Noro D; Iwamura H; Tobisawa Y; Yoneyama T; Hashimoto Y; Ohyama C
    Int Urol Nephrol; 2020 Apr; 52(4):671-679. PubMed ID: 31897875
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of Disagreement Between Two Risk Group Models on prognosis in Patients With Metastatic Renal-Cell Carcinoma.
    Okita K; Hatakeyama S; Tanaka T; Ikehata Y; Tanaka T; Fujita N; Ishibashi Y; Yamamoto H; Yoneyama T; Hashimoto Y; Yoshikawa K; Kawaguchi T; Masumori N; Kitamura H; Ohyama C
    Clin Genitourin Cancer; 2019 Jun; 17(3):e440-e446. PubMed ID: 30772204
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma.
    Zhang F; Xie Y; Ma X; Gu L; Li H; Li X; Guo G; Zhang X
    Urol Oncol; 2019 Mar; 37(3):184.e9-184.e17. PubMed ID: 30509867
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Survival from childhood cancers in Eastern Africa: A population-based registry study.
    Joko-Fru WY; Parkin DM; Borok M; Chokunonga E; Korir A; Nambooze S; Wabinga H; Liu B; Stefan C
    Int J Cancer; 2018 Nov; 143(10):2409-2415. PubMed ID: 29981149
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials-Analyses From the German Clinical RCC Registry.
    Marschner N; Staehler M; Müller L; Nusch A; Harde J; Koska M; Jänicke M; Goebell PJ;
    Clin Genitourin Cancer; 2017 Apr; 15(2):e209-e215. PubMed ID: 27720164
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
    Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
    Shagisultanova E; Gaponova AV; Gabbasov R; Nicolas E; Golemis EA
    Gene; 2015 Aug; 567(1):1-11. PubMed ID: 25967390
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy.
    Shinohara N; Obara W; Tatsugami K; Naito S; Kamba T; Takahashi M; Murai S; Abe T; Oba K; Naito S
    Cancer Sci; 2015 May; 106(5):618-26. PubMed ID: 25711777
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?
    Patel AR; Stephenson AJ
    Nat Rev Urol; 2011 Jun; 8(7):385-92. PubMed ID: 21670752
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.